We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
InspireMD Appoints Dr. James Barry to Its Board of Directors
News

InspireMD Appoints Dr. James Barry to Its Board of Directors

InspireMD Appoints Dr. James Barry to Its Board of Directors
News

InspireMD Appoints Dr. James Barry to Its Board of Directors

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "InspireMD Appoints Dr. James Barry to Its Board of Directors"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Ofir Paz, InspireMD's Chief Executive Officer and co-founder, commented, "We are pleased to have Dr. Barry join the Board of Directors. His extensive medical technology experience and reputation, in particular with interventional cardiology products, will be great assets to InspireMD. As we move forward with the further development of our MGuard™ stent technology and position the company for worldwide commercial launch, we continue to seek out seasoned industry experts who can provide support and guidance."

"I am thrilled about joining InspireMD's Board at this exciting stage in the Company's development," said Dr. Barry. "I believe that InspireMD is poised to become an important global player in interventional cardiology and look forward to assisting in the Company's advancement."

Dr. Barry has over 20 years of experience in leadership roles in the medical device industry. He is currently Executive Vice President and Chief Operating Officer at Arsenal Medical Inc.  Prior to joining Arsenal, Dr. Barry was Senior Vice President, Corporate Technology Development at Boston Scientific where he was in charge of  the Corporate R&D and Pre-clinical Sciences functions. Dr. Barry joined Boston Scientific in 1992  and oversaw its efforts in the identification and development of drug, device and biological systems for applications with implantable and catheter-based delivery systems. Under Dr. Barry's leadership, the company developed the TAXUS® paclitaxel-eluting coronary stent that became one of the most successful medical devices launched, achieving first year sales in excess of $3 billion.

Prior to Boston Scientific, Dr. Barry worked at Howmedica (Division of Pfizer) and Kontron Instruments.  He has authored multiple articles in peer reviewed publications, including several clinical journals in the cardiovascular field. He currently serves on a number of advisory boards including the College of Biomedical Engineering at Yale University, the College of Sciences at University of Massachusetts-Lowell, and the Massachusetts Life Science Center. Dr. Barry received his Ph.D. in Biochemistry from the University of Massachusetts-Lowell and holds a B.A. degree in Chemistry from Saint Anselm College.

Advertisement